BMI

From high BMI to the ‘GLP-1 look’: how weight-loss jabs are changing the face of beauty

Popular weight-loss diet shows surprising impact on serious mental health condition

The keto diet may help individuals with anorexia nervosa, new research from UC San Diego School of Medicine suggests. The small study, published in the journal Nature, enrolled 22 women between 18 and 45 years old who had a history of anorexia nervosa and a BMI (body mass index) above 17.5.Anorexia nervosa (AN) is a severe psychiatric disorder involving food restriction and low body weight, the researchers describe. This is often followed by body dissatisfaction, an intense fear of eating,...

Life-changing medicine or beauty hack? How Ozempic came to be seen as both, and why that's risky

Life-changing medicine or beauty hack? How Ozempic came to be seen as both, and why that's risky The same drug that is helping patients manage diabetes and reduce their risk of serious complications from chronic conditions is also being discussed as a beauty hack by people hoping to lose a few kilograms. Experts say more education and awareness are needed.

Keto diet shows real promise for anorexia recovery

The ketogenic diet, best known as a fat-busting fad, holds promise for treating anorexia nervosa. Following the diet – which contains high amounts of fat, moderate amounts of protein and very few carbohydrates – caused 3 in 4 people with the eating disorder to drop below the threshold for diagnosis in a small study. This is thought to be due to the diet restoring malfunctioning energy release in brain cells, which has been linked to anorexia, thereby lowering anxiety and reducing the...

Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk Popular GLP-1 weight-loss drugs may have an unexpected bonus: a significantly lower risk of breast cancer. - Date: - June 6, 2026 - Source: - University of Pennsylvania School of Medicine - Summary: - A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.

Intermittent fasting triggers surprising changes in the brain

Intermittent fasting triggers surprising changes in the brain An intermittent fasting-style diet helped obese adults lose weight while triggering coordinated changes in both their gut bacteria and brain activity. - Date: - May 31, 2026 - Source: - Frontiers - Summary: - Losing weight may involve rewiring the gut and the brain at the same time. In a study of obese adults, an intermittent fasting-style diet led to significant weight loss, healthier metabolic markers, and notable shifts in gut...

PanKbase Integrated Single-Cell Map: A Comprehensive Atlas of Human Pancreatic Islets

Abstract Aims/hypothesis Single-cell RNA sequencing (scRNA-seq) of pancreatic islet tissue is a powerful tool for investigating Type 1 Diabetes (T1D). However, individual datasets are limited in size and fragmented across donors, laboratories, and experimental conditions, highlighting the need for a unified single-cell atlas. This study aimed to construct a comprehensive, integrated scRNA-seq map of human isolated pancreatic islets by collating data from diverse sources.

Weight-loss drugs may cut breast cancer risk by up to 30%, study finds

Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study. Women who take GLP-1 medications, such as Ozempic or Mounjaro, are less likely to develop breast cancer, a new study has found. The findings, presented at the 2026 American Society of Clinical Oncology (ASCO) annual meeting, come from an analysis of more than 110,000 women aged between 45 and 80.

Fastest-rising women's cancer in Australia still has a low profile

Uterine cancer is increasing in Australia, but most women have never heard of it Sat 6 Jun 2026 at 4:53am In short: Uterine cancer is increasing in Australia, with the incidence doubling over the past 25 years. But the condition also has a poor public profile, with up to nine in 10 women having no knowledge of the disease. Up to 60 per cent of cases of uterine cancer in Australia are potentially preventable with greater public awareness, prompt attention to symptoms and better management of...

Cranio-Diff: Diffusion-based Cross-domain Craniofacial Reconstruction with 2D X-ray Skull Guidance and Structural Identity Constraints

arXiv:2606.09699v1 Announce Type: new Abstract: The state-of-the-art generative models, such as CycleGAN, Pix2Pix, and diffusion models have demonstrated remarkable performance in the face generation task. However, they fail to effectively capture cross-modality semantic information in craniofacial reconstruction when translating from the skull (x-ray) to the face (optical) domain, due to a mismatch in the alignment of structural identity across modalities. To address this issue, we propose...